Curaleaf Holdings Inc. (CURA) - Total Assets

Latest as of September 2025: CA$2.88 Billion CAD ≈ $2.09 Billion USD

Based on the latest financial reports, Curaleaf Holdings Inc. (CURA) holds total assets worth CA$2.88 Billion CAD (≈ $2.09 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Curaleaf Holdings Inc. service its debt to assess how comfortably operating cash covers total debt obligations.

Curaleaf Holdings Inc. - Total Assets Trend (2014–2024)

This chart illustrates how Curaleaf Holdings Inc.'s total assets have evolved over time, based on quarterly financial data. See CURA net assets for net asset value and shareholders' equity analysis.

Curaleaf Holdings Inc. - Asset Composition Analysis

Current Asset Composition (December 2024)

Curaleaf Holdings Inc.'s total assets of CA$2.88 Billion consist of 14.6% current assets and 85.4% non-current assets.

Asset Category Amount (CAD) % of Total Assets
Cash & Equivalents CA$107.23 Million 3.2%
Accounts Receivable CA$66.48 Million 2.3%
Inventory CA$220.65 Million 7.5%
Property, Plant & Equipment CA$768.11 Million 26.0%
Intangible Assets CA$1.09 Billion 36.8%
Goodwill CA$628.88 Million 21.3%

Asset Composition Trend (2014–2024)

This chart illustrates how Curaleaf Holdings Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Curaleaf Holdings Inc..

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Curaleaf Holdings Inc.'s current assets represent 14.6% of total assets in 2024, a decrease from 88.6% in 2014.
  • Cash Position: Cash and equivalents constituted 3.2% of total assets in 2024, down from 66.0% in 2014.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, an increase from 0.0% in 2014.
  • Asset Diversification: The largest asset category is intangible assets at 36.8% of total assets.

Curaleaf Holdings Inc. Competitors by Total Assets

Key competitors of Curaleaf Holdings Inc. based on total assets are shown below.

Company Country Total Assets
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
China CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
China CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
China CN¥925.41 Million
Jw Pharmac
KO:001060
Korea ₩605.27 Billion
Kamada
TA:KMDA
Israel ILA377.21 Million
Samjin Pharm
KO:005500
Korea ₩449.14 Billion

Curaleaf Holdings Inc. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.47 1.11 1.90
Quick Ratio 0.71 0.51 0.79
Cash Ratio 0.36 0.24 0.00
Working Capital CA$141.01 Million CA$42.96 Million CA$197.74 Million

Curaleaf Holdings Inc. - Advanced Valuation Insights

This section examines the relationship between Curaleaf Holdings Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.29
Latest Market Cap to Assets Ratio 0.85
Asset Growth Rate (YoY) -4.7%
Total Assets CA$2.95 Billion
Market Capitalization $2.52 Billion USD

Valuation Analysis

Near Book Valuation: The market values Curaleaf Holdings Inc.'s assets close to their book value (0.85x), suggesting investors view the company's assets at approximately fair value.

Slight Asset Contraction: Curaleaf Holdings Inc.'s assets decreased by 4.7% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Curaleaf Holdings Inc. (2014–2024)

The table below shows the annual total assets of Curaleaf Holdings Inc. from 2014 to 2024.

Year Total Assets Change
2024-12-31 CA$2.95 Billion
≈ $2.13 Billion
-4.75%
2023-12-31 CA$3.10 Billion
≈ $2.24 Billion
-9.31%
2022-12-31 CA$3.41 Billion
≈ $2.47 Billion
+9.97%
2021-12-31 CA$3.11 Billion
≈ $2.25 Billion
+30.10%
2020-12-31 CA$2.39 Billion
≈ $1.73 Billion
+223.86%
2019-12-31 CA$736.93 Million
≈ $533.08 Million
+29.32%
2018-12-31 CA$569.84 Million
≈ $412.21 Million
+275.88%
2017-12-31 CA$151.60 Million
≈ $109.67 Million
+317837.21%
2016-12-31 CA$47.68K
≈ $34.49K
-68.57%
2015-12-31 CA$151.70K
≈ $109.74K
+84.91%
2014-12-31 CA$82.04K
≈ $59.34K
--

About Curaleaf Holdings Inc.

TO:CURA Canada Drug Manufacturers - Specialty & Generic
Market Cap
$6.04 Billion
CA$8.35 Billion CAD
Market Cap Rank
#5360 Global
#183 in Canada
Share Price
CA$12.41
Change (1 day)
+1.06%
52-Week Range
CA$2.31 - CA$16.21
All Time High
CA$18.62
About

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinct… Read more